Correction of nutrition of patients receiving long-term therapy with glucocorticosteroids
https://doi.org/10.29039/1992-6499-2023-2-16-23
Abstract
Long-term therapy with glucocorticosteroids (GC) is widely used in rheumatic and autoimmune diseases due to their anti-inflammatory and immunosuppressive effects. However, GC therapy can also cause a number of side effects, such as loss of muscle and bone mass, increased blood pressure, metabolic disorders with the development of obesity. This review examines the available literature data in the field of dietetics and nutritionology, which can be recommended to patients who are on long-term therapy with GCS to reduce possible side effects.
About the Authors
N. A. Ilenkova
Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky
Russian Federation
Russian Federation
N.A. Ilenkova, Dr. Sci. (Med.), Professor, Head of Department
Krasnoyarsk
V. V. Chikunov
Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky
Russian Federation
Russian Federation
V.V. Chikunov, Cand. Sci. (Med.), Associate professor of Department
Krasnoyarsk
D. F. Sergienko
Astrakhan State Medical University
Russian Federation
Russian Federation
D.F. Sergienko, Dr. Sci. (Med.), Professor, Professor of the Department
Astrakhan
References
1. Van Der G. M., Jacobs J. W., Bijlsma J. W. The value of glucocorticoid co-therapy in different rheumatic diseases – positive and adverse effects. Arthritis Res Ther. 2014; 16 (Suppl 2): 2.
2. Chen S., Choi C., Li Q. Yeh W., Lee Y., Kao A., Liang M. H. Glucocorticoid use in patients with systemic lu-pus erythematosus: association between dose and health care utilization and costs. Arthritis Care Res (Hoboken). 2015;67 (8): 1086–1094.
3. Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018; 61 (1): 7–16.
4. Sale C., Elliott-Sale K. J. Nutrition and athlete bone health. Sport Med. 2019; 49 (Suppl. 2): 139–151.
5. Buckley L., Guyatt G., Fink H. A., Cannon M., Grossman J., Hansen K. E., Humphrey M. B., Lane N. E., Magrey M., Miller M., Morrison L., Rao M., Robinson A. B., Saha S., Wolver S., Bannuru R. R., Vaysbrot E., Osani M., Turgunbaev M., Miller A. S., McAlindon T. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2017; 69 (8): 1521–1537.
6. Osteoporosis. Clinical recommendations of the Ministry of Health of the Russian Federation. Moscow; 2021. 105 p. (In Russ.).
7. Kamen D. L., Cooper G. S., Bouali H., Shaftman S. R., Hollis B. W., Gilkeson G. S. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006; 5 (2): 114–117.
8. U.S. Department of Agriculture ARS. FoodData Central. 2019. URL: https://fdc.nal.usda.gov/.
9. Rondanelli M., Faliva M. A., Tartara A., Gasparri C., Perna S., Infantino V., Riva A., Petrangolini G., Peroni G. An update on magnesium and bone health. BioMetals. 2021; 34 (4): 715–736.
10. Minetto M. A., Qaisar R., Agoni V., Motta G., Longa E., Miotti D., Pellegrino M. A., Bottinelli R. Quantitative and qualitative adaptations of muscle fibers to glucocorticoids. Muscle Nerve. 2015; 52 (4): 631–639.
11. Ikizler T. A., Burrowes J. D., Byham-Gray L. D., Campbell K. L., Carrero J. J., Chan W., Fouque D., Fried-man A. N., Ghaddar S., Goldstein-Fuchs D. J., Kaysen G. A, Kopple J. D., Teta D., Wang A.E., Cuppari L. KDOQI clini-cal practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. 2020; 76 (3 Suppl 1): S1-S107.
12. Dolan E., Sale C. Protein and bone health across the lifespan. Proc Nutr Soc. 2019; 78 (1): 45–55.
13. Institute of Medicine. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: National Academies Press., 2005. 252 p.
14. Peckett A. J., Wright D. C., Riddell M. C. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism. 2011; 60 (11): 1500–1510.
15. Berthon B. S., MacDonald-Wicks L. K., Wood L. G. A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans. Nutr Res. 2014; 34 (3): 179–190.
16. Kelly O., Gilman J., Boschiero D., Ilich J. Osteosarcopenic obesity: current knowledge, revised identification criteria and treatment principles. Nutrients. 2019; 11 (4): 747.
17. Beigrezaei S., Ghiasvand R., Feizi A., Iraj B. Relationship between dietary patterns and incidence of type 2 diabetes. Int. J. Prev. Med. 2019; 10: 122.
18. Sofi F., Cesari F., Abbate R., Gensini G. F., Casini A. Adherence to Mediterranean diet and health status: me-ta-analysis. BMJ. 2008; 337: a1344.
19. Quinkler M., Stewart P. M. Hypertension and the cortisol- cortisone shuttle. J. Clin. Endocrinol. Metab. 2003; 88 (6): 2384–2392.
20. Conn H. O., Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J. Intern. Med. 1994; 236 (6): 619–632.
21. Aburto N.J., Ziolkovska A., Hooper L., Elliott P., Cappuccio F. P., Meerpohl J. J. Effect of lower sodium in-take on health: systematic review and meta- analyses. BMJ. 2013; 346: f1326.
22. Fardet L., Kettaneh A., Gerol J., Tiev K.-P., Cabane J. Effet a`court terme des apports sodes sur la pression arterielle des patients recevant une corticotherapie systemique: etude prospective, randomisee, croisee. La revue de medecine interne. 2009; 30 (9): 741–746.
Review
For citations:
Ilenkova N.A., Chikunov V.V., Sergienko D.F. Correction of nutrition of patients receiving long-term therapy with glucocorticosteroids. Astrakhan medical journal. 2023;18(2):16–23. (In Russ.) https://doi.org/10.29039/1992-6499-2023-2-16-23
Views:
669
Email this article 